ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.3620T>A (p.Ile1207Asn)

dbSNP: rs730880780
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000158615 SCV000208550 uncertain significance not provided 2022-04-06 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Invitae RCV001312375 SCV001502825 uncertain significance Hypertrophic cardiomyopathy 2020-08-29 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with MYH7-related conditions. ClinVar contains an entry for this variant (Variation ID: 181229). This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with asparagine at codon 1207 of the MYH7 protein (p.Ile1207Asn). The isoleucine residue is moderately conserved and there is a large physicochemical difference between isoleucine and asparagine.
Ambry Genetics RCV002453548 SCV002616326 uncertain significance Cardiovascular phenotype 2021-12-01 criteria provided, single submitter clinical testing The p.I1207N variant (also known as c.3620T>A), located in coding exon 25 of the MYH7 gene, results from a T to A substitution at nucleotide position 3620. The isoleucine at codon 1207 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV002484974 SCV002800936 uncertain significance Hypertrophic cardiomyopathy 1; Myopathy, myosin storage, autosomal recessive; Myosin storage myopathy; Congenital myopathy with fiber type disproportion; Dilated cardiomyopathy 1S; MYH7-related skeletal myopathy 2021-11-04 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.